{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:26:59Z","timestamp":1787304419892,"version":"build-2736575974"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"9","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jom-2025-0164_abs_001\">\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Urinary tract infections (UTIs) in pregnant women may present as asymptomatic bacteriuria (ASB) to symptomatic bladder or kidney infections (cystitis and pyelonephritis, respectively). Identifying risk factors for a UTI may allow for improved screening techniques and help facilitate preventative medicine in at-risk populations from dangerous UTI-related sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0164_abs_002\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of this study is to identify conditions associated with the increased risk of symptomatic UTIs in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0164_abs_003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized the pregnancy risk assessment monitoring system (PRAMS) Phase 8, which surveyed postpartum women from 2016 to 2021 to assess factors related to the occurrence of UTIs during pregnancy. PRAMS has respondents self-identifying ethnoracial groups, socioeconomic status (SES), and comorbidities, which we utilized to identify the associated risk of developing a UTI during pregnancy. Data within PRAMS\u2019 automated research file (ARF) regarding UTIs were only available from three states: Delaware, Michigan, and Mississippi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0164_abs_004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall prevalence of symptomatic UTIs among pregnant individuals within these states was 14.8\u202f%. From 2016 to 2021, we found significant differences in the rates of UTI occurrence from 2016\u202fat 12.7\u202f%, to highs of 16.4\u202f% in 2018 and then 16.1\u202f% in 2019. Rates from 2020 through 2021 were not significantly different than 2016 through 2021. Results also showed significant associations between depression (odds ratio [OR] = 2.18, 95\u202f% confidence interval [CI]), intimate partner violence (IPV) (OR = 2.18, 95\u202f% CI), and prescription pain relievers (OR\u202f=\u202f2.65, 95\u202f% CI) in the development of UTI during pregnancy. Maternal race affects the risk of occurrence. Compared to UTIs in White women, UTIs in Black (OR\u202f=\u202f1.22, 95\u202f% CI), American Indian (OR\u202f=\u202f2.24, 95\u202f% CI), and multiracial (OR\u202f=\u202f1.17, 95\u202f% CI) women occur more frequently in pregnancy. In contrast, Asian women are less likely to experience a UTI in pregnancy (OR\u202f=\u202f0.45, 95\u202f% CI) than white\u00a0women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0164_abs_005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to reported UTIs rates from 2000 to 2002 of 17\u202f%, our findings show that the occurrence of UTIs during pregnancy has decreased to 13\u202f%. Given the relevant significant findings, increased screening for depression and IPV may be warranted for those presenting with UTI. In addition, increased screening for UTIs in Black, American Indian, and multiracial women can help prevent the development of serious sequelae of pregnancy-associated\u00a0UTIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jom-2025-0164","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:55:26Z","timestamp":1766134526000},"page":"453-460","source":"Crossref","is-referenced-by-count":2,"title":["Associations of comorbidities, opioid use, and intimate partner violence, with urinary tract infections in pregnancy: implications for prevention and screening"],"prefix":"10.1515","volume":"126","author":[{"given":"Kathryn","family":"Donatucci","sequence":"first","affiliation":[{"name":"Center for Health Sciences , 12373 Oklahoma State University , Tulsa , OK , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Pathak","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, Office of Medical Student Research , Oklahoma State University , Tulsa , OK , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"McPherson","sequence":"additional","affiliation":[{"name":"Oklahoma State University Medical Center , Tulsa , OK , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameca","family":"Price","sequence":"additional","affiliation":[{"name":"School of Community Medicine, Department of Obstetrics and Gynecology , University of Oklahoma , Tulsa , OK , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Hartwell","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine at Cherokee Nation, Office of Medical Student Research , Oklahoma State University , Tahlequah , OK , USA"},{"name":"Center for Health Sciences, Department of Psychiatry and Behavioral Sciences , Oklahoma State University , Tulsa , OK , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2026082108562320736_j_jom-2025-0164_ref_003","doi-asserted-by":"crossref","unstructured":"Whitehead, NS, Callaghan, W, Johnson, C, Williams, L. Racial, ethnic, and economic disparities in the prevalence of pregnancy complications. Matern Child Health J 2009;13:198\u2013205. https:\/\/doi.org\/10.1007\/s10995-008-0344-2.","DOI":"10.1007\/s10995-008-0344-2"},{"key":"2026082108562320736_j_jom-2025-0164_ref_004","unstructured":"Habak, PJ, Carlson, K, Griggs, RPJr. Urinary tract infection in pregnancy. Treasure Island, FL: StatPearls Publishing; 2024."},{"key":"2026082108562320736_j_jom-2025-0164_ref_005","doi-asserted-by":"crossref","unstructured":"Gilstrap, LC, Ramin, SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin N Am 2001;28:581\u201391. https:\/\/doi.org\/10.1016\/s0889-8545(05)70219-9.","DOI":"10.1016\/S0889-8545(05)70219-9"},{"key":"2026082108562320736_j_jom-2025-0164_ref_006","unstructured":"Barbara, WT, Nicolas, WC-P, Kalpana, G, Elizabeth, BH, Molly, H, Gregory, JM, et al.. Complicated urinary tract infections (cUTI). Clinical guidelines for treatment and management. IDSA; 2025. https:\/\/www.idsociety.org\/practice-guideline\/complicated-urinary-tract-infections\/ [Accessed 1 Oct 2025]."},{"key":"2026082108562320736_j_jom-2025-0164_ref_008","unstructured":"Preterm, labor. The Mayo Clinic. https:\/\/www.mayoclinic.org\/diseases-conditions\/preterm-labor\/symptoms-causes\/syc-20376842 [Accessed 18 Jan 2025]"},{"key":"2026082108562320736_j_jom-2025-0164_ref_009","doi-asserted-by":"crossref","unstructured":"Jolley, JA, Kim, S, Wing, DA. Acute pyelonephritis and associated complications during pregnancy in 2006 in US hospitals. J\u00a0Matern Fetal Neonatal Med 2012;25:2494\u20138. https:\/\/doi.org\/10.3109\/14767058.2012.704441.","DOI":"10.3109\/14767058.2012.704441"},{"key":"2026082108562320736_j_jom-2025-0164_ref_007","doi-asserted-by":"crossref","unstructured":"Johnson, CY, Rocheleau, CM, Howley, MM, Chiu, SK, Arnold, KE, Ailes, EC. Characteristics of women with urinary tract infection in pregnancy. J\u00a0Womens Health 2021;30:1556\u201364. https:\/\/doi.org\/10.1089\/jwh.2020.8946.","DOI":"10.1089\/jwh.2020.8946"},{"key":"2026082108562320736_j_jom-2025-0164_ref_010","doi-asserted-by":"crossref","unstructured":"Pastore, LM, Savitz, DA, Thorp, JMJr, Koch, GG, Hertz-Picciotto, I, Irwin, DE. Predictors of symptomatic urinary tract infection after 20\u00a0weeks\u2019 gestation. J\u00a0Perinatol 1999;19:488\u201393. https:\/\/doi.org\/10.1038\/sj.jp.7200264.","DOI":"10.1038\/sj.jp.7200264"},{"key":"2026082108562320736_j_jom-2025-0164_ref_011","doi-asserted-by":"crossref","unstructured":"Schieve, LA, Handler, A, Hershow, R, Persky, V, Davis, F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health 1994;84:405\u201310. https:\/\/doi.org\/10.2105\/AJPH.84.3.405.","DOI":"10.2105\/AJPH.84.3.405"},{"key":"2026082108562320736_j_jom-2025-0164_ref_012","unstructured":"Delzell, JEJ, Lefevre, ML. Urinary tract infections during pregnancy. Am Fam Physician 2000;61:713\u201321."},{"key":"2026082108562320736_j_jom-2025-0164_ref_013","doi-asserted-by":"crossref","unstructured":"Cox, S, Reid, F. Urogynaecological complications in pregnancy: an overview. Obstet Gynaecol Reprod Med 2015;25:123\u20137. https:\/\/doi.org\/10.1016\/j.ogrm.2015.02.002.","DOI":"10.1016\/j.ogrm.2015.02.002"},{"key":"2026082108562320736_j_jom-2025-0164_ref_014","doi-asserted-by":"crossref","unstructured":"Storme, O, Saucedo, JT, Garcia-Mora, A, Dehesa-D\u00e1vila, M, Naber, KG. Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol 2019;11:1756287218814382. https:\/\/doi.org\/10.1177\/1756287218814382.","DOI":"10.1177\/1756287218814382"},{"key":"2026082108562320736_j_jom-2025-0164_ref_015","doi-asserted-by":"crossref","unstructured":"Al-Bash, MR, Mathew, M, Al-Kharusi, LA, Abu-Heija, AT. Symptomatic urinary tract infection in diabetic pregnant women, effect of the type of diabetes and glycemic control. Saudi J Med Med Sci 2016;4:104\u20137. https:\/\/doi.org\/10.4103\/1658-631x.178327.","DOI":"10.4103\/1658-631X.178327"},{"key":"2026082108562320736_j_jom-2025-0164_ref_016","doi-asserted-by":"crossref","unstructured":"Dachew, BA, Scott, JG, Alati, R. Gestational urinary tract infections and the risk of antenatal and postnatal depressive and anxiety symptoms: a longitudinal population-based study. J\u00a0Psychosom Res 2021;150:110600. https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110600.","DOI":"10.1016\/j.jpsychores.2021.110600"},{"key":"2026082108562320736_j_jom-2025-0164_ref_017","doi-asserted-by":"crossref","unstructured":"James, PR, Nelson-Piercy, C. Management of hypertension before, during, and after pregnancy. Heart 2004;90:1499. https:\/\/doi.org\/10.1136\/hrt.2004.035444.","DOI":"10.1136\/hrt.2004.035444"},{"key":"2026082108562320736_j_jom-2025-0164_ref_018","doi-asserted-by":"crossref","unstructured":"Gates, MA, Hall, SA, Chiu, GR, Kupelian, V, Fitzgerald, MP, Link, CL, et al.. Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey. Am J Epidemiol 2011;173:1022. https:\/\/doi.org\/10.1093\/aje\/kwq473.","DOI":"10.1093\/aje\/kwq473"},{"key":"2026082108562320736_j_jom-2025-0164_ref_019","unstructured":"Teuteberg, W. Drug-Induced Acute Urinary Retention. Palliative Care Network of Wisconsin. PCNOW; 2019. https:\/\/www.mypcnow.org\/fast-fact\/drug-induced-acute-urinary-retention\/ [Accessed 21 Sep 2025]."},{"key":"2026082108562320736_j_jom-2025-0164_ref_020","unstructured":"Urinary Tract Infection (UTI). Cleveland Clinic; 2023. https:\/\/my.clevelandclinic.org\/health\/diseases\/9135-urinary-tract-infections [Accessed 21 Sep 2025]."},{"key":"2026082108562320736_j_jom-2025-0164_ref_021","doi-asserted-by":"crossref","unstructured":"Alhusen, JL, Ray, E, Sharps, P, Bullock, L. Intimate partner violence during pregnancy: maternal and neonatal outcomes. J\u00a0Womens Health 2015;24:100. https:\/\/doi.org\/10.1089\/jwh.2014.4872.","DOI":"10.1089\/jwh.2014.4872"},{"key":"2026082108562320736_j_jom-2025-0164_ref_022","doi-asserted-by":"crossref","unstructured":"Hartwell, M, Keener, A, Robling, K, Enmeier, M, Sajjadi, NB, Greiner, B, et al.. Associations of intimate partner violence and maternal comorbidities: a cross-sectional analysis of the pregnancy risk assessment monitoring system. J\u00a0Osteopath Med 2023;123:405\u201310. https:\/\/doi.org\/10.1515\/jom-2023-0018.","DOI":"10.1515\/jom-2023-0018"},{"key":"2026082108562320736_j_jom-2025-0164_ref_023","doi-asserted-by":"crossref","unstructured":"Yefet, E, Bejerano, A, Iskander, R, Kimhi, TZ, Nachum, Z. The association between gestational diabetes mellitus and infections in pregnancy\u2014systematic review and meta-analysis. Microorganisms 2023;11:1956. https:\/\/doi.org\/10.3390\/microorganisms11081956.","DOI":"10.3390\/microorganisms11081956"},{"key":"2026082108562320736_j_jom-2025-0164_ref_024","doi-asserted-by":"crossref","unstructured":"Schneeberger, C, Erwich, JJHM, van den Heuvel, ER, Mol, BWJ, Ott, A, Geerlings, SE. Asymptomatic bacteriuria and urinary tract infection in pregnant women with and without diabetes: cohort study. Eur J Obstet Gynecol Reprod Biol 2018;222:176\u201381. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.12.013.","DOI":"10.1016\/j.ejogrb.2017.12.013"},{"key":"2026082108562320736_j_jom-2025-0164_ref_025","doi-asserted-by":"crossref","unstructured":"Yan, L, Jin, Y, Hang, H, Yan, B. The association between urinary tract infection during pregnancy and preeclampsia: a meta-analysis. Am Fam Physician 2018;97:e12192. https:\/\/doi.org\/10.1097\/md.0000000000012192.","DOI":"10.1097\/MD.0000000000012192"},{"key":"2026082108562320736_j_jom-2025-0164_ref_002","unstructured":"ACOG. Urinary tract infections in pregnant individuals; 2024. Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/clinical-consensus\/articles\/2023\/08\/urinary-tract-infections-in-pregnant-individuals."},{"key":"2026082108562320736_j_jom-2025-0164_ref_026","unstructured":"USPSTF. Screening for asymptomatic bacteriuria in adults: recommendation statement. Am Fam Physician 2020;101:489\u201392."},{"key":"2026082108562320736_j_jom-2025-0164_ref_027","doi-asserted-by":"crossref","unstructured":"Getaneh, T, Negesse, A, Dessie, G, Desta, M, Tigabu, A. Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis. BioMed Res Int 2021;2021:6551526. https:\/\/doi.org\/10.1155\/2021\/6551526.","DOI":"10.1155\/2021\/6551526"},{"key":"2026082108562320736_j_jom-2025-0164_ref_028","unstructured":"Social determinants of health literature summaries. Healthy People 2030. https:\/\/odphp.health.gov\/healthypeople\/priority-areas\/social-determinants-health\/literature-summaries. [Accessed 1 Oct 2025]."}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0164\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:56:45Z","timestamp":1787302605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0164\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,24]]},"published-print":{"date-parts":[[2026,8,24]]}},"alternative-id":["10.1515\/jom-2025-0164"],"URL":"https:\/\/doi.org\/10.1515\/jom-2025-0164","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}